Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 40026 - 40050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Exemestane	Approved Investigational	KLK7	5650	upregulated	exemestane results in increased expression of KLK7 mRNA	19q13.33	A20550
Exemestane	Approved Investigational	METRN	79006	upregulated	exemestane results in increased expression of METRN mRNA	16p13.3	A20550
Exemestane	Approved Investigational	MYBL2	4605	upregulated	exemestane results in increased expression of MYBL2 mRNA	20q13.12	A20550
Exemestane	Approved Investigational	MYO9B	4650	upregulated	exemestane results in increased expression of MYO9B mRNA	19p13.11	A20550
Exemestane	Approved Investigational	OSTM1	28962	upregulated	exemestane results in increased expression of OSTM1 mRNA	6q21	A20550
Exemestane	Approved Investigational	PGR	5241	upregulated	exemestane results in increased expression of PGR mRNA	11q22.1	A21347
Exemestane	Approved Investigational	PLCG2	5336	upregulated	exemestane results in increased expression of PLCG2 mRNA	16q24.1	A20550
Exemestane	Approved Investigational	RNF123	63891	upregulated	exemestane results in increased expression of RNF123 mRNA	3p21.31	A20550
Exemestane	Approved Investigational	RRP12	23223	upregulated	exemestane results in increased expression of RRP12 mRNA	10q24.1	A20550
Exemestane	Approved Investigational	SLC13A4	26266	upregulated	exemestane results in increased expression of SLC13A4 mRNA	7q33	A20550
Exemestane	Approved Investigational	SNHG20	654434	upregulated	exemestane results in increased expression of SNHG20 mRNA	17q25.2	A20550
Exemestane	Approved Investigational	TBC1D17	79735	upregulated	exemestane results in increased expression of TBC1D17 mRNA	19q13.33	A20550
Exemestane	Approved Investigational	TFF1	7031	upregulated	exemestane results in increased expression of TFF1 mRNA	21q22.3	A21347
Exemestane	Approved Investigational	TMEM155	132332	upregulated	exemestane results in increased expression of TMEM155 mRNA	4q27	A20550
Exemestane	Approved Investigational	TNFRSF14	8764	upregulated	exemestane results in increased expression of TNFRSF14 mRNA	1p36.32	A20550
Exemestane	Approved Investigational	TP53TG1	11257	upregulated	exemestane results in increased expression of TP53TG1 mRNA	7q21.12	A20550
Exemestane	Approved Investigational	TRIOBP	11078	upregulated	exemestane results in increased expression of TRIOBP mRNA	22q13.1	A20550
Exemestane	Approved Investigational	XIST	7503	upregulated	exemestane results in increased expression of XIST mRNA	Xq13.2	A20550
Ezetimibe	Approved Investigational	ABCA1	19	downregulated	Ezetimibe results in decreased expression of ABCA1 mRNA	9q31.1	A22607
Ezetimibe	Approved Investigational	NPC1L1	29881	downregulated	Ezetimibe results in decreased expression of NPC1L1 mRNA	7p13	A22607
Ezetimibe	Approved Investigational	NR1H2	7376	downregulated	Ezetimibe results in decreased expression of NR1H2 mRNA	19q13.3	A22607
Ezetimibe	Approved Investigational	RARG	5916	downregulated	Ezetimibe results in decreased expression of RARG mRNA	12q13.13	A22607
Ezetimibe	Approved Investigational	SCARB1	949	downregulated	Ezetimibe results in decreased expression of SCARB1 mRNA	12q24.31	A22607
Ezetimibe	Approved Investigational	SREBF1	6720	downregulated	Ezetimibe results in decreased expression of SREBF1 mRNA	17p11.2	A22607
Ezetimibe	Approved Investigational	SREBF2	6721	downregulated	Ezetimibe results in decreased expression of SREBF2 mRNA	22q13.2	A22607

Displaying entries 40026 - 40050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability